Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 7
1980 1
1986 2
1987 3
1988 1
1991 2
1992 1
1993 2
1995 1
1998 2
1999 1
2002 1
2004 2
2006 4
2007 2
2008 2
2009 3
2010 1
2011 4
2012 1
2013 2
2014 1
2015 2
2017 1
2018 1
2019 1
2020 2
2021 1
2022 1
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.
Ramos EL, Dayan CM, Chatenoud L, Sumnik Z, Simmons KM, Szypowska A, Gitelman SE, Knecht LA, Niemoeller E, Tian W, Herold KC; PROTECT Study Investigators. Ramos EL, et al. N Engl J Med. 2023 Dec 7;389(23):2151-2161. doi: 10.1056/NEJMoa2308743. Epub 2023 Oct 18. N Engl J Med. 2023. PMID: 37861217 Clinical Trial.
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG; Protégé Trial Investigators. Sherry N, et al. Lancet. 2011 Aug 6;378(9790):487-97. doi: 10.1016/S0140-6736(11)60931-8. Epub 2011 Jun 28. Lancet. 2011. PMID: 21719095 Free PMC article. Clinical Trial.
Are all HCL systems the same? long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study.
Santova A, Plachy L, Neuman V, Pavlikova M, Petruzelkova L, Konecna P, Venhacova P, Skvor J, Pomahacova R, Neumann D, Vosahlo J, Strnadel J, Kocourkova K, Obermannova B, Pruhova S, Cinek O, Sumnik Z. Santova A, et al. Among authors: skvor j. Front Endocrinol (Lausanne). 2023 Oct 16;14:1283181. doi: 10.3389/fendo.2023.1283181. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37908748 Free PMC article.
Type 1 diabetes incidence increased during the COVID-19 pandemic years 2020-2021 in Czechia: Results from a large population-based pediatric register.
Cinek O, Slavenko M, Pomahačová R, Venháčová P, Petruželková L, Škvor J, Neumann D, Vosáhlo J, Konečná P, Kocourková K, Strnadel J, Průhová Š, Šumník Z; ČENDA Register. Cinek O, et al. Among authors: skvor j. Pediatr Diabetes. 2022 Nov;23(7):956-960. doi: 10.1111/pedi.13405. Epub 2022 Sep 5. Pediatr Diabetes. 2022. PMID: 35982508 Free PMC article.
Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry.
Šumník Z, Pavlíková M, Pomahačová R, Venháčová P, Petruželková L, Škvor J, Neumann D, Vosáhlo J, Konečná P, Čížek J, Strnadel J, Průhová Š, Cinek O; ČENDA Project Group. Šumník Z, et al. Among authors: skvor j. Pediatr Diabetes. 2021 May;22(3):439-447. doi: 10.1111/pedi.13184. Epub 2021 Feb 17. Pediatr Diabetes. 2021. PMID: 33533545
Five years of improving diabetes control in Czech children after the establishment of the population-based childhood diabetes register ČENDA.
Šumník Z, Venháčová J, Škvor J, Pomahačová R, Konečná P, Neumann D, Vosáhlo J, Strnadel J, Čížek J, Obermannová B, Petruželková L, Průhová Š, Pavlíková M, Cinek O; ČENDA Project Group. Šumník Z, et al. Among authors: skvor j. Pediatr Diabetes. 2020 Feb;21(1):77-87. doi: 10.1111/pedi.12929. Epub 2019 Oct 16. Pediatr Diabetes. 2020. PMID: 31605416
58 results